Form D — Cambrian BioPharma Inc
0000897069-25-000101 · filed 2025-01-13
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $37,602,297
- Total sold
- $23,022,065
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Cambrian BioPharma Inc
- CIK
- 1797409
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 228 PARK AVENUE S.
NEW YORK, NY 10003 - Phone
- (516) 962-3186
Related persons
-
James G. Peyer · Executive OfficerNew York, NY
-
Christian Angermayer · DirectorNew York, NY
-
Maryanna Saenko · DirectorNew York, NY
-
Brenton Saunders · DirectorNew York, NY
-
Paul Farr · DirectorNew York, NY
View original on SEC EDGAR.